Blog - Email Marketing & Digital Messaging

Every single marketing message has strategy behind it. Whether or not that strategy is strategic or not is ultimately up to the marketer.

Over a four-part blog post series, I’ll explore each of these best practices to help pharma marketers revolutionize their current strategies to achieve marketing excellence. This first post focuses on the traditional approach to email, as many pharma marketers would like to move away from traditional email development.

In our rapidly evolving digital marketing ecosystem, email has remained a staple among marketers. It is widely used as an effective non-personal channel for both consumers and HCPs. But if you're wondering if you're sending too much, you're not alone.

Here are four keys to maximizing your role as a valued digital messaging partner.

It is critical to move away from an ad hoc approach incorporating email into your campaign strategy, and to take a more analytic approach to the frequency, content, cadence, and targeting of your overall email communication.

There are multiple ways to acquire email IDs but the ‘pop-up window on the landing page’ has proven more effective for acquiring new email IDs. Going that route requires sensitivity given users' negative associations with pop-ups.

Merkle has a wide array of performance marketing strategies and tactics at its disposal to drive response. Often these techniques use cutting-edge digital technologies or modeling techniques, and sometimes both. But just as often, we find that low-tech approaches can generate response magic too.

Email isn't dead, but getting optimal value of the channel requires relying on one or several methods to measure correctly. Here is a Princess Bride-themed look at what marketers can do to get ROUS’s — rodents of unusual size returns of unusual sizes.